BCL
HAIAW

Bracebridge Capital LLC’s Healthcare AI Acquisition Corp. Warrants HAIAW Stock Holding History

Bracebridge Capital LLC’s Portfolio HAIAW Stock Details HAIAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-121,400
Closed -$3.04K – 46
2024
Q3 		$3.04K Hold
121,400
– – ﹤0.01% 32
2024
Q2 		$4.86K Hold
121,400
– – ﹤0.01% 30
2024
Q1 		$5.63K Hold
121,400
– – ﹤0.01% 32
2023
Q4 		$3.06K Hold
121,400
– – ﹤0.01% 33
2023
Q3 		$5.34K Hold
121,400
– – ﹤0.01% 33
2023
Q2 		$10.6K Buy
+121,400
New +$7.48K 0.01% 33

Other funds holding HAIAW

Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Bracebridge Capital LLC's HAIAW Position: Q4 2024 in Review

Bracebridge Capital LLC sold out of Healthcare AI Acquisition Corp. Warrants (HAIAW) in Q4 2024, closing a stake of 121,400 shares — an estimated $3.04K sold.

Bracebridge Capital LLC first reported a position in HAIAW in Q2 2023 and held it in 6 quarters. The position peaked at $10.6K in Q2 2023. 3 funds tracked by Wall St. Rank hold HAIAW as of Q4 2024.

  • Bracebridge Capital LLC reported no remaining Healthcare AI Acquisition Corp. Warrants position as of Q4 2024 after selling out during the quarter.
  • Bracebridge Capital LLC sold 121,400 Healthcare AI Acquisition Corp. Warrants shares in Q4 2024, an estimated $3.04K.
  • Bracebridge Capital LLC first reported a position in Healthcare AI Acquisition Corp. Warrants in Q2 2023 and held it in 6 quarters.
  • Bracebridge Capital LLC's Healthcare AI Acquisition Corp. Warrants position peaked at $10.6K in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Healthcare AI Acquisition Corp. Warrants as of Q4 2024.

Based on Bracebridge Capital LLC's 13F filing for Q4 2024, filed 14 Feb 2025.